We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon
Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
… Metastasis is now responsible for around 90 % of the deaths in cancer but there are no available drugs now in the market focusing on preventing metastasis. Foxy-5 may be the first.
…
Maybe the first produced by a drug company. I'm not so sure you can say that inclusive of Mother Nature. While there are no double blind studies, some doctors have reported anecdotal evidence that breast and prostate cancers can both be prevented and reversed if treated early with hormone balancing in principal, in practice progesterone supplementation. The tendency for progesterone to have a regulatory effect, the presence of progesterone receptors in many types of body tissue, and the pattern of deterioration (or tumor formation) in many of those increasing in later years when progesterone levels have dropped, is prompting widespread research into the potential value of maintaining progesterone levels in both males and females. - Progesterone - Wikipedia. The drug companies don't have any skin in that treatment, though. Molecules found in nature can't be patented.
In the U.S., the medical industry first became aware of this avenue of treatment back when it was discovered in 1974 that a deficiency of the 5a reductase enzyme and DHT was the etiology behind a genetic mutation that produced male children with ambiguous sexual characteristics who had underdeveloped prostates after becoming adults. Finasteride (brand names Proscar, and Propecia by Merck) a 5a reductase inhibitor, was later developed by Merck for treatment of benign prostate hyperplasia and approved in 1992. It appears that no real attempt has been made to find and treat what may be the cause or trigger of excess 5a reductase in older men, which brings me to the reason for my post, my light hearted but heartfelt little rant.
Today's medical establishment is much more interested in treatment [for life] than they are in cause discovery and remediation. That's understandable when it comes to drug companies. It is somewhat disheartening when it comes to doctors. But, doctors are courted heavily by the drug companies and prescribing drugs is the mainstay of the MD's professional practice. After all, MD means Doctor of Medicine. Find a man you can cure, and you'll eat for a day. Find a man you can treat for life and you'll feed your whole family from now on.
To save myself from writing a very long winded explanation, here's a link to some very interesting explanations of the links between hormonal imbalance and prostate hyperplasia as well as evidence that breast cancer and prostate cancer are really the same disease with the same etiology.
